Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery

Head and Neck

Volumn 36, Issue 5, 2014, Pages 652-659

  Canis, Martin ^a   Ihler, Friedrich ^a   Martin, Alexios ^b   Wolff, Hendrik A ^a   Matthias, Christoph ^a   Steiner, Wolfgang ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

functional outcomes; oncologic results; organ preservation; T3 laryngeal carcinoma; transoral laser microsurgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CASE STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; LARYNX EDEMA; LASER MICROSURGERY; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MICROLARYNGOSCOPY; MICROSURGERY; MULTIMODALITY CANCER THERAPY; NASOGASTRIC TUBE; NECK DISSECTION; ORAL SURGERY; OVERALL SURVIVAL; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; SECOND CANCER; TRACHEOTOMY; TREATMENT FAILURE; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; DISEASE FREE SURVIVAL; EVALUATION STUDY; FEASIBILITY STUDY; GLOTTIS; KAPLAN MEIER METHOD; LARYNGEAL NEOPLASMS; LOW LEVEL LASER THERAPY; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SURGERY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR INVASION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; GLOTTIS; HUMANS; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LASER THERAPY; MALE; MICROSURGERY; MIDDLE AGED; MINIMALLY INVASIVE SURGICAL PROCEDURES; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGAN SPARING TREATMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84899049429     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23338     Document Type: Article

References (48)

1. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR,. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124: 951-962.
2. Sikora AG, Toniolo P, DeLacure MD,. The changing demographics of head and neck squamous cell carcinoma in the United States. Laryngoscope 2004; 114: 1915-1923.
3. Strong MS, Jako GJ,. Laser surgery in the larynx. Early clinical experience with continuous CO 2 laser. Ann Otol Rhinol Laryngol 1972; 81: 791-798.
4. Steiner W,. Experience in endoscopic laser surgery of malignant tumours of the upper aero-digestive tract. Adv Otorhinolaryngol 1988; 39: 135-144.
5. Steiner W,. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol 1993; 14: 116-121.
6. Steiner W, Ambrosch P, Hess CF, Kron M,. Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg 2001; 124: 58-67.
7. Canis M, Ihler F, Wolff HA, Christiansen H, Matthias C, Steiner W,. Oncologic and functional results after transoral laser microsurgery of tongue base carcinoma. Eur Arch Otorhinolaryngol 2013; 270: 1075-1083.
8. Sobin LH, Compton CC,. TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 2010; 116: 5336-5339.
9. Steiner W, Ambrosch P,. Endoscopic laser surgery of the upper aerodigestive tract. Stuttgart, Germany: Thieme; 2000. pp 100-104.
10. Werner JA, Lippert BM, Schünke M, Rudert H,. [Animal experiment studies of laser effects on lymphatic vessels. A contribution to the discussion of laser surgery segmental resection of carcinomas]. [Article in German] Laryngorhinootologie 1995; 74: 748-755.
11. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116 (9 Pt 2 Suppl 111): 1-13.
12. Razack MS, Maipang T, Sako K, Bakamjian V, Shedd DP,. Management of advanced glottic carcinomas. Am J Surg 1989; 158: 318-320.
13. Bryant GP, Poulsen MG, Tripcony L, Dickie GJ,. Treatment decisions in T3N0M0 glottic carcinoma. Int J Radiat Oncol Biol Phys 1995; 31: 285-293.
14. Foote RL, Olsen KD, Buskirk SJ, Stanley RJ, Suman VJ,. Laryngectomy alone for T3 glottic cancer. Head Neck 1994; 16: 406-412.
15. Biller HF, Lawson W,. Partial laryngectomy for vocal cord cancer with marked limitation or fixation of the vocal cord. Laryngoscope 1986; 96: 61-64.
16. Lesinski SG, Bauer WC, Ogura JH,. Hemilaryngectomy for T3 (fixed cord) epidermoid carcinoma of larynx. Laryngoscope 1976; 86: 1563-1571.
17. Piquet JJ, Desaulty A, Pilliaert JM, Decroix G,. [Results of surgical treatment of cancers of the endolarynx]. [Article in French] Acta Otorhinolaryngol Belg 1973; 27: 916-923.
18. Vega SF, Scola B, Vega MF, Martinez T, Scola E,. [Laryngeal vertical partial surgery. Surgical techniques. Oncological and functional results]. [Article in Italian] Acta Otorhinolaryngol Ital 1996; 16: 272-280.
19. Chevalier D, Laccourreye O, Brasnu D, Laccourreye H, Piquet JJ,. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol 1997; 106: 364-369.
20. Piquet JJ, Chevalier D,. Subtotal laryngectomy with crico-hyoido- epiglotto-pexy for the treatment of extended glottic carcinomas. Am J Surg 1991; 162: 357-361.
21. Laccourreye O, Laccourreye L, Muscatello L, Périé S, Weinstein G, Brasnu D,. Local failure after supracricoid partial laryngectomy: symptoms, management, and outcome. Laryngoscope 1998; 108: 339-344.
22. Jørgensen K, Godballe C, Hansen O, Bastholt L,. Cancer of the larynx-treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients. Acta Oncol 2002; 41: 69-76.
23. Harwood AR, Beale FA, Cummings BJ, Hawkins NV, Keane TJ, Rider WD,. T3 glottic cancer: an analysis of dose time-volume factors. Int J Radiat Oncol Biol Phys 1980; 6: 675-680.
24. Parsons JT, Mendenhall WM, Mancuso AA, Cassisi NJ, Stringer SP, Million RR,. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx. Head Neck 1989; 11: 123-128.
25. Wylie JP, Sen M, Swindell R, Sykes AJ, Farrington WT, Slevin NJ,. Definitive radiotherapy for 114 cases of T3N0 glottic carcinoma: influence of dose-volume parameters on outcome. Radiother Oncol 1999; 53: 15-21.
26. Solares CA, Wood B, Rodriguez CP, et al. Does vocal cord fixation preclude nonsurgical management of laryngeal cancer? Laryngoscope 2009; 119: 1130-1134.
27. Laccourreye O, Salzer SJ, Brasnu D, Shen W, Laccourreye H, Weinstein GS,. Glottic carcinoma with a fixed true vocal cord: outcomes after neoadjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Otolaryngol Head Neck Surg 1996; 114: 400-406.
28. Ambrosch P, Rödel R, Kron M, Steiner W,. [Transoral laser microsurgery for cancer of the larynx. A retrospective analysis of 657 patients]. [Article in German] Onkologe 2001; 7: 505-512.
29. Bocca E. Sixteenth, Daniel C. Baker, Jr, memorial lecture. Surgical management of supraglottic cancer and its lymph node metastases in a conservative perspective. Ann Otol Rhinol Laryngol. 1991; 100 (4 Pt 1): 261-267.
30. Isaacs JH Jr, Slattery WH III, Mendenhall WM, Cassisi NJ,. Supraglottic laryngectomy. Am J Otolaryngol 1998; 19: 118-123.
31. Burstein FD, Calcaterra TC,. Supraglottic laryngectomy: series report and analysis of results. Laryngoscope 1985; 95 (7 Pt 1): 833-836.
32. Schwaab G, Kolb F, Julieron M, et al. Subtotal laryngectomy with cricohyoidopexy as first treatment procedure for supraglottic carcinoma: Institut Gustave-Roussy experience (146 cases, 1974-1997). Eur Arch Otorhinolaryngol 2001; 258: 246-249.
33. Bron L, Brossard E, Monnier P, Pasche P,. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas. Laryngoscope 2000; 110: 627-634.
34. Chevalier D, Piquet JJ,. Subtotal laryngectomy with cricohyoidopexy for supraglottic carcinoma: review of 61 cases. Am J Surg 1994; 168: 472-473.
35. Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Robbins KT,. Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck 2002; 24: 456-467.
36. Nakfoor BM, Spiro IJ, Wang CC, Martins P, Montgomery W, Fabian R,. Results of accelerated radiotherapy for supraglottic carcinoma: a Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary experience. Head Neck 1998; 20: 379-384.
37. Sykes AJ, Slevin NJ, Gupta NK, Brewster AE,. 331 cases of clinically node-negative supraglottic carcinoma of the larynx: a study of a modest size fixed field radiotherapy approach. Int J Radiat Oncol Biol Phys 2000; 46: 1109-1115.
38. Iro H, Waldfahrer F, Altendorf-Hofmann A, Weidenbecher M, Sauer R, Steiner W,. Transoral laser surgery of supraglottic cancer: follow-up of 141 patients. Arch Otolaryngol Head Neck Surg 1998; 124: 1245-1250.
39. Hinni ML, Salassa JR, Grant DG, et al. Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007; 133: 1198-1204.
40. Rudert HH, Werner JA, Höft S,. Transoral carbon dioxide laser resection of supraglottic carcinoma. Ann Otol Rhinol Laryngol 1999; 108: 819-827.
41. Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC,. Transoral laser microsurgery for carcinoma of the supraglottic larynx. Otolaryngol Head Neck Surg 2007; 136: 900-906.
42. Vilaseca I, Bernal-Sprekelsen M, Luis Blanch J,. Transoral laser microsurgery for T3 laryngeal tumors: prognostic factors. Head Neck 2010; 32: 929-938.
43. de Vincentiis M, Minni A, Gallo A, Di Nardo A,. Supracricoid partial laryngectomies: oncologic and functional results. Head Neck 1998; 20: 504-509.
44. Robbins KT, Davidson W, Peters LJ, Goepfert H,. Conservation surgery for T2 and T3 carcinomas of the supraglottic larynx. Arch Otolaryngol Head Neck Surg 1988; 114: 421-426.
45. Herranz-González J, Gavilán J, Martinez-Vidal J, Gavilán C,. Supraglottic laryngectomy: functional and oncologic results. Ann Otol Rhinol Laryngol 1996; 105: 18-22.
46. Krespi Y, Kheterpal U,. Laryngeal surgery. In:, Krespi YP, Ossof RH, editors. Complications in head and neck surgery. Philadelphia, PA: Saunders; 1993. pp 215-231.
47. Scola B, Fernández-Vega M, Martínez T, Fernández- Vega S, Ramirez C,. Management of cancer of the supraglottis. Otolaryngol Head Neck Surg 2001; 124: 195-198.
48. Spriano G, Antognoni P, Sanguineti G, et al. Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy. Am J Otolaryngol 2000; 21: 14-21.